Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders??? Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 1 $ 29,758 $ (36,530) $ (6,771)
Balance (in Shares) at Dec. 31, 2020 7,599,716      
Stock option exercise 4 4
Stock option exercise (in Shares)       25,000      
Canceled restricted stock awards
Canceled restricted stock awards (in Shares)       (60,000)      
Reclassification of warrant liabilities 3,566 3,566
Issuance of common stock and warrants, net of fees 19,326 19,326
Issuance of common stock and warrants, net of fees (in Shares)       4,772,500      
Issuance of common stock and preferred stock in connection with conversion of notes 19,222 19,222
Issuance of common stock and preferred stock in connection with conversion of notes (in Shares) 251 1,443 500,756 1,261,277      
Repurchased beneficial conversion feature in connection with conversion of notes payable (6,647) (6,647)
Issuance of common stock warrants in connection with note exchange agreements 4,918 4,918
Exercise of common stock warrants 180 180
Exercise of common stock warrants (in Shares)       219,199      
Issuance of common stock to consultants 247 247
Issuance of common stock to consultants (in Shares)       64,954      
Stock-based compensation 5,802 5,802
Stock-based compensation (in Shares)       1,038,095      
Net loss (26,071) (26,071)
Balance at Jun. 30, 2021 $ 1 76,376 (62,601) 13,776
Balance (in Shares) at Jun. 30, 2021 251 1,443 500,756 14,920,741      
Balance at Mar. 31, 2021 $ 1 73,789 (57,203) 16,587
Balance (in Shares) at Mar. 31, 2021 251 1,443 500,756 14,856,480      
Issuance of common stock in connection with a consulting agreement 244 244
Issuance of common stock in connection with a consulting agreement (in Shares)       64,261      
Stock option exercise 4 4
Stock-based compensation 2,339 2,339
Net loss   (5,398) (5,398)
Balance at Jun. 30, 2021 $ 1 76,376 (62,601) 13,776
Balance (in Shares) at Jun. 30, 2021 251 1,443 500,756 14,920,741      
Balance at Dec. 31, 2021 $ 1 82,677 (73,690) 8,988
Balance (in Shares) at Dec. 31, 2021 251 1,443 500,756 14,530,126      
Delivery of restricted common stock
Delivery of restricted common stock (in Shares)       33,332      
Issuance of common stock warrants in connection with SLOC 223 223
Issuance of Series D preferred stock and warrants, net of fees
Issuance of common stock/At-the-market offering, net of offering costs 58   58
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)       51,169      
Stock-based compensation 2,531 2,531
Net loss (9,047) (9,047)
Balance at Jun. 30, 2022 $ 1 85,489 (82,737) 2,753
Balance (in Shares) at Jun. 30, 2022 251 1,443 500,756 14,614,627      
Balance at Mar. 31, 2022 $ 1 83,983 (78,260) 5,724
Balance (in Shares) at Mar. 31, 2022 251 1,443 500,756 14,563,458      
Issuance of Series D preferred stock and warrants, net of fees 1 1
Issuance of common stock/At-the-market offering, net of offering costs 58 58
Issuance of common stock/At-the-market offering, net of offering costs (in Shares)       51,169      
Stock-based compensation 1,448 1,448
Net loss (4,477) (4,477)
Balance at Jun. 30, 2022 $ 1 $ 85,489 $ (82,737) $ 2,753
Balance (in Shares) at Jun. 30, 2022 251 1,443 500,756 14,614,627